Dabur India Limited
C
Corporate
P
Profile fil August ugust 2013
0 3

Agenda

Dabur India-Introduction
FMCG Industry Scenario
Business Overview
Strategy Overview
Recent Performance

2

Introduction
 Established in 1884 ‐ more than 128
Years of Trust & Excellence
 World’s largest in Ayurveda and natural healthcare
 Sales of Rs. 61.5 billion and profits of l f b ll d f f Rs. 7.6 billion in FY2012‐13

Dabur ranked amongst the
Top 5 Indian companies with the best Board of Directors

Dabur India Ltd Bags Golden
Peacock Award For Excellence p In Corporate Governance 2012
In FMCG Sector

 20 world class manufacturing facilities
20
ld l f t i f iliti catering to needs of diverse markets
 Strong overseas presence with 31%
Strong overseas presence with 31% contribution to consolidated sales

14

billion Rupee brands

Dabur bags People's Choice
Corporate Green Star Award for 2012 for its environment‐ focussed initiatives

58
5.8

Dabur ranked amongst India's
Most Admired Companies by
Forbes India

mn retail outlet reach in India
3

Vision and Core Values
Vision

• Dedicated to the health and well being of every household

Ownership
Passion
for
Winning

Integrity

Core
Values

People
Developm
ent

Innovation

Team
Workk

Consumer
Focus
4

Key Milestones
1884

1972

1986

•Dr. SK Burman started an Ayurvedic Pharmacy in Kolkatta

•The company shifted base to Delhi from
Kolkata

•Registered as Public
Limited Company

1994

1998

2003

•Listed
Li t d on the th Bombay
B
b
Stock Exchange

•Professionalized
P f i li d with ith Burman Family handing over day to management •Pharmaceutical
Ph
ti l B
Business
i de-merged to focus on core FMCG business

2004

2005

2006

International Business
•International
set up in Dubai to tap overseas opportunity

Acquired Balsara
•Acquired
strengthening Oral care
& gaining entry into
Home care

Dabur Figured in Top 10
•Dabur
Great Places To Work

2008

2010

2013

•Acquired Fem Care
Ph
Pharma entering t i mainstream Skin care

• Overseas acquisitions -

•Crossed Rs. 60 bn mark in annual sales and
Market Cap of US$5 billion Hobi Group,
Group Turkey and
Namaste Labs, US

5

Performance Overview
Sales
in INR bn
28.1

33.9

FY09

FY10

52.8

40.8

FY11

FY12

61.5

“Robust profitable growth translating into superior shareholder returns”

FY13

Market Capitalization
Market Capitalization in INR bn

EBITDA

238.9

in INR bn
16.0
14.0
12.0
10.0
8.0
6.0

5.2

6.7

8.3

9.5

FY11

FY12

11 2
11.2

137 8
137.8

167.2

185.4

85.4

4.0
2.0
0.0

FY09

FY10

FY09

FY10

FY11

FY12

FY13

Profit after Tax

11 0
11.0

in INR bn
9.0
7.0
5.0

FY13

3.9

5.0

5.7

6.4

FY10

FY11

FY12

7.6

30
3.0
1.0
‐1.0

FY09

FY13

6

Business Footprint
UK
Turkey

U.S.

Egypt

UAE

Nepal

B’Desh
Nigeria

Sri Lanka

Domestic Mfg.
Locations

Key markets
Manufacturing Facilities

Our strategy is to localize manufacturing, supply chain and product offerings to suit consumer requirements in each geography
7

Our Billion Rupee Brands

Home &
Personal Care

Health Care

Foods
8

Research & Development Focus
Team of scientists including
Ayurvedic doctors, Pharmacists,
Agronomists, Botanists, Tissue
Culture specialists, etc.

Strong New Product Development
 Ayurvedic Medicines
 Personal Care
 Foods
 Home Care

A
Agro
Bi
Biotech
t h Initiatives
I iti ti

 OTC Healthcare

 Protecting endangered herbs
 Technical assistance to farmers
 Contract cultivation of herbs
 Green House at Nepal

Dabur Research Facilities

“Nearly 25 new products and variants introduced in FY 2013” d d
”
Agronomy Initiatives : Greenhouse at Dabur
Nepal & Uttaranchal
Nepal & Uttaranchal

9

Dabur - Domestic Distribution Structure
Factory
Depot

Stockists

Super stockists

((Carry & Forward Agents) y g
)

Insti Stockists

Modern Trade
Stockist

Wholesalers

Sub stockists
Sub stockists

Retail trade

Rural trade

Shoppers & Consumers

Insti customers

Direct reach 0.8 mn outlets

“Total reach at 5.8 mn retail outlets, one of the